Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Reactogenicity & Immunogenicity of Tdap in Pregnancy

Vaccine; ePub 2018 Sep 13; Fortner, et al

Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine was well-tolerated in both pregnant and nonpregnant women, with pain at injection site more likely in pregnant women, a recent study found. Researchers compared local injection-site and systemic reactions and serologic response following Tdap in pregnant women (gestational age 20-34 weeks) and nonpregnant women and in pregnant women by self-reported prior Tdap receipt. Injection-site and systemic reactions were assessed for 1 week post-vaccination. They found:

  • 374 pregnant and 225 nonpregnant women were vaccinated.
  • Severe local or systemic reactions or “any” fever were uncommon in both groups.
  • Moderate/severe injection-site pain was significantly higher in pregnant vs nonpregnant women (18% vs 11%) but did not necessitate a healthcare visit.
  • Prior Tdap receipt did not increase occurrence of moderate/severe local or systemic reactions in pregnant women.
  • Serologic responses to all vaccine antigens were robust.

Citation:

Fortner KB, Swamy GK, Broder KR, et al. Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women. [Published online ahead of print September 13, 2018]. Vaccine. doi:10.1016/j.vaccine.2018.07.012.

Commentary:

This study highlights that the Tdap vaccine is very well tolerated. The side effect of local pain is a very well-expected phenomenon. The side effect was more common in pregnant women in this study, but this localized tenderness was mild and transient. The study showed that the vaccine had a good immune response which is important if we will give this vaccine every pregnancy to protect newborns from tetanus and pertussis. —John Russell, MD

This Week's Must Reads

AHA Statement: Accurate Measurement of BP, Hypertension; ePub 2019 Mar 4; Muntner, et al

Coffee Consumption & Plasma Biomarkers, Am J Clin Nutr; ePub 2019 Mar 5; Hang, et al

Is Adding Aspirin to Warfarin Therapy Beneficial? , JAMA Intern Med; ePub 2019 Mar 4; Schaefer, et al

Urinary Oxalate Excretion & Risk of CKD Progression, JAMA Intern Med; ePub 2019 Mar 4; Waikar, et al

Psychosocial Stress & CV Health in Older Women, Circulation; ePub 2019 Feb 28; Burroughs-Peña, et al

Must Reads in Vaccines

Vaccination for Prevention of Herpes Zoster, Ann Intern Med; ePub 2019 Feb 19; Prosser, et al

ACIP Updates Adult Immunization Schedule, Ann Intern Med; 2019 Feb 5; Kim, Hunter, et al

Influenza Vaccination Safety During Hospitalization, Mayo Clin Proc; ePub 2019 Jan 8; Tartof, et al

Acellular Pertussis Vaccine Is Safe & Effective, JAMA Pediatr; 2018 Nov; Wood, Nolan, et al

Influenza and Pertussis Vaccination in Pregnancy, Vaccine; ePub 2018 Nov 3; Wilcox, Bottrell, et al